Chemotherapy for breast cancer during pregnancy: Is epirubicin safe?

Annals of Oncology

Volumn 19, Issue 10, 2008, Pages 1814-1815

  Mir, Olivier ^a,b,c   Berveiller, P ^c,d   Rouzier, R ^c,e   Goffinet, F ^b,c   Goldwasser, F ^a,c   Treluyer, J M ^b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c CALG Group   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GLYCOPROTEIN P; METHOTREXATE; NAVELBINE; PACLITAXEL; PREDNISONE; TAXANE DERIVATIVE; TRASTUZUMAB; VINCRISTINE;

BREAST CANCER; DRUG INDICATION; DRUG INTOXICATION; DRUG RESPONSE; DRUG SAFETY; FETAL WELL BEING; HUMAN; LETTER; MATERNAL WELFARE; MEDICAL DECISION MAKING; PLACENTA PERFUSION; PLACENTAL TRANSFER; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SECOND TRIMESTER PREGNANCY; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY;

EID: 53049110683     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn553     Document Type: Letter

References (18)

1. Mir O, Berveiller P, Ropert S et al. Emerging therapeutic options for breast cancer during pregnancy. Ann Oncol 2008; 19: 607-613.
2. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004; 15: 146-150.
3. Loibl S, von Minckwitz G, Gwyn K et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 2006; 106: 237-246.
4. Goldwasser F, Pico JL, Cerrina J et al. Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient. Leuk Lymphoma 1995; 20: 173-176.
5. Müller T, Hofmann J, Steck T. Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996; 67: 197-198.
6. Bodner-Adler B, Bodner K, Zeisler H. Breast cancer diagnosed during pregnancy. Anticancer Res 2007; 27: 1705-1707.
7. Mathelin C, Annane K, Dufour P et al. Chemotherapy for breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 123: 260-262.
8. Andreadis C, Charalampidou M, Diamantopoulos N et al. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer. Gynecol Oncol 2004; 95: 252-255.
9. Peccatori F, Martinelli G, Gentilini O, Goldhirsch A. Chemotherapy during pregnancy: What is really safe? Lancet Oncol 2004; 5: 398.
10. Ginopoulos PV, Michail GD, Kourounis GS. Pregnancy associated breast cancer: A case report. Eur J Gynaecol Oncol 2004; 25: 261-263.
11. Gadducci A, Cosio S, Fanucchi A et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: Case report and review of the literature. Anticancer Res 2003; 23: 5225-5529.
12. Cuvier C, Espie M, Extra JM, Marty M. Vinorelbine in pregnancy. Eur J Cancer 1997; 33: 168-169.
13. Peres RM, Sanseverino MT, Guimaraes JL et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: A multicenter study. Braz J Med Biol Res 2001; 34: 1551-1559.
14. Giacalone PL, Laffargue F, Bénos P. Chemotherapy for breast carcinoma during pregnancy: A French national survey. Cancer 1999; 86: 2266-2272.
15. Azim HA Jr, Peccatori FA. Treatment of metastatic breast cancer during pregnancy: We need to talk! Breast 2008. Published on April 30, 2008. doi: 10.1016/j.breast.2008.02.005.
16. Azim HA Jr, Peccatori FA, Scarfone G et al. Anthracyclines for gestational breast cancer: Course and outcome of pregnancy. Ann Oncol 2008; 19: 1511-1512.
17. Grohard P, Akbaraly JP, Saux MC et al. Transplacental passage of doxorubicin. J Gynecol Obstet Biol Reprod 1989; 18: 595-600.
18. Gaillard B, Leng JJ, Grellet J et al. Transplacental passage of epirubicin. J Gynecol Obstet Biol Reprod 1995; 24: 63-68.